Jashwant Kumar

Jashwant Kumar

Auto-generated profile, based on publicly available information

Jashwant Kumar

Research and Development Department Intas Pharmaceuticals Limited, Biopharma Division Ahmedabad Gujarat India

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 March 2025
Verified
Preprint
Open access
JKJashwant Kumar
Jashwant Kumar
RSReema Sultana
Reema Sultana
DSDeeksha Saripalla
Deeksha Saripalla
VCViki Chopda
Viki Chopda
LALaxmi Adhikary
Laxmi Adhikary
Biosimilar development of monoclonal antibodies (mAbs) is gaining significant momentum as numerous blockbuster biologics approach their patent expiry in the current decade. A critical challenge in biosimilar development lies in achieving product quality attributes comparable to the innovator product. The product quality attributes (PQAs) in upstream processing are influenced by multiple factors, including cell line selection, media composition, feed strategy, supplements, and bioreactor process parameters, with physical parameter optimization playing a pivotal role in enhancing both product titer and modulating PQAs. In this study, we systematically evaluated the impact of physical process parameters - pH, temperature, and initial seeding density - on N-glycan profiles and charge variants across four biosimilar development projects (Projects 1-4). Prediction models were developed using JMP software to establish parameter-attribute relationships. Our results demonstrated that lowering bioreactor pH reduced % acidic variants and % Afucosylation (AF) while increasing % basic variants and % galactosylation. Similarly, increased culture temperature resulted in lower % acidic variants and % AF. This knowledge base was successfully applied to expedite the development of a fifth mAb biosimilar development (Project 5), substantially reducing experimental iterations and development timelines, exemplifying the practical implementation of Bioprocessing 4.0 principles.

23 October 2025 in Biotechnology Progress
Verified
Journal Article
Closed access
JKJashwant Kumar
Jashwant Kumar
RSReema Sultana
Reema Sultana
DSDeeksha Saripalla
Deeksha Saripalla
VCViki Chopda
Viki Chopda
VMVelu Mahalingam
Velu Mahalingam
LALaxmi Adhikary
Laxmi Adhikary